Phase II study of Regorafenib as single agent for the treatment of patients with metastatic colorectal cancer with any RAS or BRAF mutation and previously treated with FOLFOXIRI plus bevacizumab

Valladares Ayerbes, Manuel; López López, Rafael; Salgado Fernández, Mercedes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/1478

DOI: 10.1093/annonc/mdv233.269

ISSN: 0923-7534

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

ANNALS OF ONCOLOGY

Type of content

Publicación de congreso